AGTR1 and Hypertension: To combat hypertension and cardiac failure pharmacological RAS manipulations have aimed to inhibit the overstimulation of AT1R, with selective or unselective blockade (sartans or ACE inhibitors), through renin inhibition (aliskiren) or combined AT1R/neprilysin inhibition (sacubitril) (32).